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manner. For example, Ab enhancement was achieved by
induction of epileptic seizure activity in the hippocam-
pus. One might assume, therefore, that patients with ep-
ilepsy would be at higher risk of Ab accumulation; how-
ever, that has proven not to be the case. Instead, this
model of transient increase in Ab release may be closer
to that seen following traumatic brain injury, a known
risk factor for AD, where there is a brief rise in Ab levels
detected in brain and cerebrospinal fluid (Chen et al.,
2004). In turn, this is correlated to formation of diffuse
amyloid deposits in the brain. Notably, while the physio-
logical relevance of synaptically released Ab is not
completely understood at present, the fact that pharma-
cological inhibition of synaptic vesicle release can de-
crease extracellular Ab by nearly 90% is certainly strong
evidence that this pool of Ab is a potentially significant
source of Ab. Future studies will undoubtedly shed
more light on its functional importance.
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Mutations in torsinA cause dominantly inherited early-
onset torsion dystonia in humans. In this issue ofNeu-
ron, Goodchild et al. show that torsinA knockout andknockin mice have similar phenotypes, which sug-
gests that themutant torsinA allele causes disease be-
cause it has decreased function. The experiments also
highlight the possible role of nuclear envelope dynam-
ics in maintaining normal neuronal function.
Many neurological diseases have variants that are
caused by gene defects. The relationships between
Mendelian forms of disease and their sporadic counter-
parts can be debated, but there is a chance of under-
standing the basic pathways leading to neuronal dys-
function. However, the usefulness of this information is
predicated on understanding how the mutation ‘‘works’’
in a genetic sense. For example, a recessive mutation is
usually associated with loss of function, which could be
tested experimentally if one has an assay for the protein
activity. Dominant mutations may work in any number of
ways, by increasing the activity of the protein, introduc-
ing a new toxic property to the protein such as protein
misfolding (gain of novel function), or acting to reduce
the activity of the endogenous protein (dominant nega-
tive). These distinctions are critical for designing the
right experiment to test hypotheses about how diseases
are caused and misapplication really causes problems
in interpretation. Such information may also change
how we design therapeutic strategies and hence is of
significant interest.
The genetics of the human dystonias are complicated
as there are at least 15 extant loci with different pheno-
typic presentations (Klein, 2005). The first identified
gene was named torsinA by Ozelius and colleagues
and is associated with early-onset torsion dystonia
(Ozelius et al., 1997). All torsinA-related dystonia cases
found so far are due to the deletion of one of a pair of glu-
tamate residues (E302/303) toward the C terminus of the
encoded protein. TorsinA is part of the large AAA+ family
of ATPases and the glutamate deletion is near to the ATP
binding region. An interesting aspect of the genetics of
torsinA dystonia is that there is greatly reduced pene-
trance. About one third of patients who carry the causal
DE302/303 mutation go on to develop disease, the rest
remaining asyptomatic. It is also worth noting that the
there appears to be a time-dependent window for sus-
ceptibility. Generally, mutation carriers who are asymp-
tomatic in their early 20s remain so throughout life, al-
though there may be exceptions (Bressman et al.,
2000). This implies that there is a critical timing for the
expression of symptoms, also implying that dystonia is
a developmental disease.
The interpretation of this human genetic evidence is
not simple because there are multiple reasonable ex-
planations for both the low penetrance dominant dis-
ease and the developmental effects. The study by
Goodchild et al. is important because it addresses this
problem in a careful but direct manner. The question
posed by the experiments is: how closely does the
DE302/303 mutation resemble a loss of function allele?
The authors address this by comparing the phenotypes
of mice with a knockout of torsinA or a knockin mutation
in which one of the pair of glutamate residues is re-
moved. If the two mice are similar in phenotype, this
would argue quite strongly and in a relevant in vivo
context, that the mutation causes a loss of function.
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thereafter because of a failure to feed. The same is
true of homozygous knockin mice with two copies of
theDE302/303 allele. Therefore, torsinA is indispensable
for one or more developmental processes, and the
mutant allele behaves as a null mutation. Critically, mice
with a single DE302/303 allele on a knockout back-
ground have the same phenotype, showing that the
mutant protein fails to act where the wild-type protein
would be sufficient to rescue the perinatal lethality.
Furthermore, the homozygous knockout and knockin
mice have a morphological phenotype, with small
balloon-like extrusions of the nuclear. The deficit is seen
in several CNS regions but only in neurons, not in glia or in
nonneural tissues. Several previous studies have impli-
cated the nuclear envelope, a specialized subcompart-
ment of the endoplasmic reticulum, as being important in
the pathological effects of torsinA. TorsinA mutants se-
lectively accumulate here (Bragg et al., 2004; Gonzalez-
Alegre and Paulson, 2004; Goodchild and Dauer, 2004;
Naismith et al., 2004), and there are two possible protein
interaction partners for torsinA in this subcellular com-
partment (Goodchild and Dauer, 2005).
Therefore, the homozygous knockout and knockin
mice have similar phenotypes for both neonatal viability
and cellular morphology. Although these experiments
clearly suggest that mutant torsinA has decreased func-
tion, they do not specifically address whether mutant
torsinA has a dominant-negative effect on the function
of endogenous protein. Such an effect is feasible if, as
previously suggested (Breakefield et al., 2001), torsinA
functions as part of an oligomer whose net activity is de-
creased by the incorporation of inactive monomers. The
current study also shows that net protein levels for
torsinA are lower in the knockin mice than in wild-types.
This suggests that part of the effect of the torsinA muta-
tion might be to decrease the stability of the monomeric
protein. Whether this also affects wild-type proteins
in the same complex is not addressed but is possible.
Because homozygous DE302/303 mice with the ob-
served phenotypes have more protein than heterozy-
gous knockout mice without the phenotypes, this con-
firms that not all of the effect is due to protein levels
and that the DE302/303 mutant must have intrinsically
lower activity than wild-type torsinA.
Such considerations might have implications for spo-
radic dystonia. Recent work (Clarimon et al., 2005) has
shown an association between a G deletion at the 30
untranslated region of the gene encoding torsinA and
the risk of suffering from idiopathic dystonia in a series
from Iceland. Because the average age at onset of pa-
tients harboring the G deletion is 36 years old in the Ice-
landic series, the present results indicate that some
cases of primary dystonia including late onset dystonia
might be caused by dominantly acting, but less disrup-
tive, mutations in the gene. Because regulatory motifs
are frequent at 30UTRs, it is possible that this polymor-
phism might lead to lower mRNA and protein levels.
Of course, there are many questions that now need to
be addressed following this work. The most obvious is
to ask why neurons have this specific requirement for
torsinA. Goodchild et al. suggest that the phenotype is
seen in postmigratory (and presumably postmitotic)
neurons, potentially linking torsinA to the disassemblyof the nucleokinesis apparatus after neuronal migration.
In favor of this hypothesis, at least one torsinA homolog
(ooc-5 fromC. elegans) participates in the rotation of nu-
clei during early embryonic development. However, the
relationship between the nuclear envelope and the cellu-
lar and systems effects of mutations in humans is ob-
scure. Dystonia is not generally a degenerative disease
and therefore is thought to derive from an altered func-
tion of neurons, likely those in circuits in the basal gan-
glia important for voluntary movements. One would
therefore imagine that the neurons in dystonia patients
are present in normal numbers, but are over or under ac-
tive. A priori, the most obvious place to look at this type
of behavior would be out at the synapses. Very specula-
tively, perhaps dystonia is a disease of altered nuclear-
synpatic communication that manifests itself after im-
portant developmental decisions in neurons after they
have completed cell migration. For example, there are
several nuclear envelope proteins that link to the cyto-
skeleton (Gruenbaum et al., 2005), which is also critical
in anchoring synaptic components in neurons.
Really understanding why torsinA has such an impor-
tant role in postmigratory neuronal development or
function will only be possible once we understand the
molecular mechanism(s) involved in its action. It is as-
sumed that the ATPase activity of torsin is important in
controlling protein substrates because many AAA+ pro-
teins are critical for the disassembly of multiprotein
complexes or unfold single substrates. But what the crit-
ical substrates are and, again, why neurons are so reliant
on these is not yet known. The torsinA knockout mice
may be very valuable in testing possible substrates for
their contribution to the torsinA phenotype.
It should also be noted that the homozygous mice
have a severe phenotype, whereas heterozygous mice
(which have the same genetic lesion as patients with
torsinA dystonia) do not exhibit these phenotypes. Per-
haps in the heterozygote state, there are more subtle dis-
turbances that manifest in altered neuronal activity with
limited changes in the nuclear envelope. Very recently,
heterozygous knockin mice for the same allele have been
reported that have subtle behavioral changes (Dang
et al., 2005). It will be critical to compare the behaviors
of the two lines of heterozygous knockin mice (Dang
et al., 2005; Goodchild et al., 2005) with the heterozygous
knockout mice as they age. If similar behavioral and neu-
rochemical abnormalities present themselves in the het-
erozygous knockout state, then this would argue that
mutant torsinA is a relatively simple loss-of-function
mutation and that although 50% activity is sufficient to
support many cells, neuronal function is compromised
under the same conditions. In contrast, if the pheno-
types can be separated from each other, especially if the
heterozygous knockout mice have no phenotype, this
might argue that mutant torsinA has a dominant-
negative effect. Given that the tools are now available,
this would be a critical way to describe how mutations
work and to begin to understand how torsinA causes
disease.
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afferents to both the major input and output station of
the amygdala, are inhibited during action of dopamine
viaD1 receptors, andare thus likely to represent impor-
tant cellular players during dopaminergic disinhibition
related to increased affective behavior.
Almost everybody has experienced a stressful or threat-
ening event that has influenced their emotional behav-
ior, in particular in relation to fear and anxiety. Accumu-
lating evidence indicates that inhibitory GABAergic
transmission in the amygdala and modulation through
the transmitter dopamine (DA) are critically involved in
this. First, the amygdala plays a central role in imbuing
sensory events with an affective value and transducing
it into behavioral responses via projections into relevant
brain regions (Maren and Quirk, 2004). Second, activity
of amygdaloid projection neurons is under inhibitory
control through GABAergic mechanisms (Royer et al.,
1999; Szinyei et al., 2000). Third, DA is increased under
stress in the amygdala (Inglis and Moghaddam, 1999)
and enhances amygdala-related behavior, most likely
through a reduction of inhibition (Rosenkranz and Grace,
1999). While this line of evidence seems straightforward,
there is a major caveat to this when it comes to correlat-
ing cellular effects of DA to behavioral outcome. Spe-
cifically, recordings from identified GABAergic inter-
neurons in the amygdala demonstrated a depolarizing
response to DA (Kro¨ner et al., 2005), which increased
rather than reduced inhibitory signals and which is diffi-
cult to reconcile with a disinhibitory effect of DA on
amygdala-related behavior.
In this issue of Neuron, Marowsky and colleagues
(Marowsky et al., 2005) present an elegant piece of
work in which they identify the cellular substrates of
DA-induced disinhibition in the amygdala. To do this,
they used mice described first by Tamamaki et al. (2003),
in which enhanced green fluorescent protein (EGFP)
is expressed under the control of the promoter for
GAD67, a key enzyme for GABA synthesis. The GAD67-
GFP mice display reliable GFP labeling of GABAergic
neurons, and they allowed Marowsky et al. to visualize
subsets of GABAergic neurons in slice preparations of
the amygdala in vitro. In a meticulous series of experi-
ments, the basic properties of GABA neurons, the synap-
tic connectivity and the responsiveness to DA, were
characterized through whole-cell recording from single
and synaptically connected pairs of neurons combined
with microstimulation. With the focus on the basolateral
amygdaloid complex (BLA), which comprises the major
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Gate Masters of the Amygdala,
Mastered by Dopamine
A hyperdopaminergic state, such as stress, is asso-
ciated with an increase in affective behavior. In this is-
sue of Neuron, Marowsky and colleagues identify two
clusters of paracapsular intercalated GABA neurons
in amygdala slice preparations of GAD67-GFP mice.
These GABA neurons mediate inhibition from cortical
afferent input station of the amygdala, two major popula-
tions of GABAergic neurons were discerned: ‘‘local’’
GABAergic interneurons scattered in the BLA, and para-
capsular intercalated cells (pcs) organized in two clus-
ters. One cluster of intercalated cells (the lateral sub-
division, lpc) is located along the external capsule. A
second cluster of intercalated cells (the medial subdivi-
sion, mpc) is located at the border between the BLA
and the central amygdaloid nucleus (CeA) and is thereby
situated between the major input and output station of
the amygdala. The lpcs, whose properties and connec-
tivity are described here for the first time, turned out to
make a most interesting contribution. Their properties in-
clude a small size, a poorly developed dendritic tree,
